Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76.5Revenue $M44.3Net Margin (%)-1,957.1Altman Z-Score-48.3
Enterprise Value $M77.6EPS $-0.8Operating Margin %-1,887.8Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-1,977.2Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-59.1Quick Ratio1.4Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %-39.4Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-130.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,081.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M232ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-72.17view
BIANCO JAMES APresident and CEO 2016-01-29Sell10,000$1.2-73.33view
SINGER JACK WEVP, Chief Scientific Officer 2016-01-29Sell15,000$1.18-72.88view
BIOTECHNOLOGY VALUE FUND L P 2016-01-08Buy1,001,327$1.22-73.77view
Plunkett MatthewEVP, Chief Business Officer 2016-01-04Sell10,000$1.21-73.55view
BIANCO JAMES APresident and CEO 2015-12-30Sell110,000$1.26-74.6view
SINGER JACK WEVP Global Medical Affairs 2015-12-18Sell15,000$1.18-72.88view
Plunkett MatthewEVP, Corporate Development 2015-12-04Sell10,000$1-68view
BIANCO JAMES APresident and CEO 2015-11-27Sell10,000$1.23-73.98view
SINGER JACK WEVP, Global Medical Affairs 2015-11-27Sell15,000$1.21-73.55view

Quarterly/Annual Reports about CTIC:

    News about CTIC:

    Articles On GuruFocus.com
    Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

    More From Other Websites
    Robbins Arroyo LLP: CTI Biopharma Corp. (CTIC) Misled Shareholders According to a Recently Filed... Feb 11 2016
    SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against CTI BioPharma... Feb 11 2016
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of... Feb 11 2016
    Kirby McInerney LLP Advises CTI BioPharma Corp. Investors of Potential Claims Feb 11 2016
    4 Stocks That Are Trading Higher In The Face of the Down Market Today Feb 11 2016
    The Zacks Analyst Blog Highlights: Regeneron, Alexion, CTI BioPharma, BioCryst and Sarepta Feb 11 2016
    IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against CTI... Feb 10 2016
    Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against CTI BioPharma Corp. Feb 10 2016
    CTI BioPharma's Myelofibrosis Drug on Full Clinical Hold Feb 10 2016
    CTI-Baxalta Drug Withdrawn, Removing Potential Incyte Rival Feb 10 2016
    3 Big Stocks You Should Stay Away From Right Now Feb 10 2016
    CTI BioPharma Stumbles Over Full Clinical Hold Feb 10 2016
    IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Ongoing Investigation of Claims against CTI... Feb 10 2016
    CTI BioPharma NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess... Feb 10 2016
    INVESTOR ALERT: Investigation of CTI BioPharma Corp. Announced by Law Offices of Howard G. Smith Feb 10 2016
    Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma Feb 10 2016
    Early Briefing on Biotechnology Stocks -- Achillion Pharma, CTI BioPharma, Inovio Pharma, and Keryx... Feb 10 2016
    CTI BioPharma downgraded by Piper Jaffray, WallachBeth and Ladenburg Thalmann Feb 10 2016
    CTI BIOPHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements... Feb 10 2016
    2:36 am CTI BioPharma reports Pacritinib has been placed on full clinical hold; co withdraws its NDA Feb 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK